| Without SCD | With SCD | P-value |
---|---|---|---|
Number of participants | 4897 | 182 | Â |
Continuous variables, Mean ± SD | |||
 Age (year) | 53.30 ± 9.77 | 62.62 ± 10.16 |  < 0.01 |
 BMI (kg/m2) | 27.89 ± 4.58 | 27.48 ± 5.04 | 0.24 |
 WC (cm) | 92.63 ± 11.20 | 94.94 ± 11.87 |  < 0.01 |
 WHR | 0.91 ± 0.08 | 0.96 ± 0.08 |  < 0.01 |
 SBP (mmHg) | 125.70 ± 20.59 | 137.45 ± 25.58 |  < 0.01 |
 DBP (mmHg) | 80.00 ± 11.30 | 82.70 ± 14.29 |  < 0.01 |
 RHR (beat/min) | 78.35 ± 11.40 | 78.18 ± 12.80 | 0.85 |
 FPG (mg/dl) | 104.36 ± 37.91 | 127.28 ± 64.10 |  < 0.01 |
 HDL-C (mg/dl) | 41.69 ± 10.94 | 41.18 ± 11.26 | 0.54 |
 TG (mg/dl) | 165 (115–233)* | 166 (118–235)* | 0.90 |
Categorical variables, number (%) | |||
 Men | 2174 (44.39) | 120 (65.93) |  < 0.01 |
 Current smoking, yes | 761 (15.54) | 42 (23.08) |  < 0.01 |
 Family History of premature CVD, yes | 905 (18.48) | 27 (14.84) | 0.21 |
 Glucose-lowering drug use, yes | 302 (6.17) | 33 (18.13) |  < 0.01 |
 Antihypertensive drug use, yes | 527 (10.76) | 42 (23.08) |  < 0.01 |
 Lipid-lowering drug use, yes | 239 (4.88) | 13 (7.14) | 0.17 |